HLA Loci Predisposing to Immune TTP in Japanese: Potential Role of the Shared ADAMTS13 Peptide Bound to Different HLA-DR
Overview
Authors
Affiliations
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare autoimmune disorder caused by neutralizing anti-ADAMTS13 autoantibodies. In white individuals, HLA allele DRB1*11 is a predisposing factor for iTTP, whereas DRB1*04 is a protective factor. However, the role of HLA in Asians is unclear. In this study, we analyzed 10 HLA loci using next-generation sequencing in 52 Japanese patients with iTTP, and the allele frequency in the iTTP group was compared with that in a Japanese control group. We identified the following HLA alleles as predisposing factors for iTTP in the Japanese population: DRB1*08:03 (odds ratio [OR], 3.06; corrected P [Pc] = .005), DRB3/4/5*blank (OR, 2.3; Pc = .007), DQA1*01:03 (OR, 2.25; Pc = .006), and DQB1*06:01 (OR,: 2.41; Pc = .003). The estimated haplotype consisting of these 4 alleles was significantly more frequent in the iTTP group than in the control group (30.8% vs 6.0%; Pc < .001). DRB1*15:01 and DRB5*01:01 were weak protective factors for iTTP (OR, 0.23; Pc = .076; and OR, 0.23, Pc = .034, respectively). On the other hand, DRB1*11 and DRB1*04 were not associated with iTTP in the Japanese. These findings indicated that predisposing and protective factors for iTTP differ between Japanese and white individuals. HLA-DR molecules encoded by DRB1*08:03 and DRB1*11:01 have different peptide-binding motifs, but interestingly, bound to the shared ADAMTS13 peptide in an in silico prediction model.
Congenital thrombotic thrombocytopenic purpura and human leukocyte antigen analysis-an amazing clue.
Kikili C, Kivanc D, Senturk Ciftci H, Ozbalak M, Yenerel M, Nalcaci M Hematol Transfus Cell Ther. 2025; 47(1):103746.
PMID: 39954327 PMC: 11872523. DOI: 10.1016/j.htct.2025.103746.
Petito E, Bury L, Antunes Heck L, Sadler B, De Candia E, Podda G Br J Haematol. 2024; 206(1):290-295.
PMID: 39462764 PMC: 11739772. DOI: 10.1111/bjh.19838.
Pandey S, Shrivastava A, Harville Y, Cottler-Fox M, Harville T Hematol Transfus Cell Ther. 2024; 46 Suppl 5:S170-S180.
PMID: 38631980 PMC: 11670648. DOI: 10.1016/j.htct.2023.11.016.
Khan T, Ledoux I, Aziz F, Al Ali F, Chin-Smith E, Ata M J Allergy Clin Immunol Glob. 2023; 2(3):100117.
PMID: 37779520 PMC: 10509938. DOI: 10.1016/j.jacig.2023.100117.
Ohto H, Ito S, Srivastava K, Ogiyama Y, Uchikawa M, Nollet K Transfusion. 2023; 63(8):1601-1611.
PMID: 37465939 PMC: 10528739. DOI: 10.1111/trf.17465.